A Director at Dexcom is Exercising Options

By Carrie Williams

Yesterday, a Director at Dexcom, Jay Skyler, exercised options of Dexcom for $2.64M.

Following Jay Skyler’s last DXCM Sell transaction on May 09, 2018, the stock climbed by 1.8%. In addition to Jay Skyler, 3 other DXCM executives reported Sell trades in the last month.

See today’s analyst top recommended stocks >>

Based on Dexcom’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $184 million and GAAP net loss of $24.2 million. In comparison, last year the company earned revenue of $142 million and had a GAAP net loss of $41.7 million. Currently, Dexcom has an average volume of 673.1K. The Company has a Price to Book ratio of 18.0796.

Based on 13 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $78.11, reflecting a 10.8% upside. Three different firms, including Goldman Sachs and Northland Securities, currently also have a Sell rating on the stock.

In the last 30 days, insiders have sold $6.44M worth of DXCM shares and purchased $21.78K worth of DXCM shares. The insider sentiment on Dexcom has been negative according to 85 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

DexCom, Inc. is a medical device manufacturing company, which engages in the design, development, and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G4 PLATINUM System, Dexcom studio and Mobile apps.